| Gastric Carcinoma altered in cohorts of …ALTERED_INderived200 of 364show all (up to 200) |
|---|
| ← altered in cohorts of | CSMD3 305 / 443 cases (69 %) · ssm · TCGA-STAD · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | FER1L6 299 / 443 cases (67 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYC 296 / 443 cases (67 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POU5F1B 294 / 443 cases (66 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASAP1 293 / 443 cases (66 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DDX27 292 / 443 cases (66 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL14A1 290 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF831 290 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GSDMC 289 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NFATC2 289 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANXA13 288 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL38 288 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WASHC5 288 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATAD2 287 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EXT1 287 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM91A1 287 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXO32 287 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRATD2 287 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SQLE 287 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADNP 286 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCSTAMP 286 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ESRP1 286 / 443 cases (65 %) · ssm · TCGA-STAD · largest of 2 cohorts | — | — | Gastric Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNV1 286 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNTB1 286 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMYND8 286 / 443 cases (65 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYRIB 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTSS1 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NSMCE2 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF139 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TAF2 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFRSF11B 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIB1 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRMT12 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VIRMA 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZHX1 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF217 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF572 285 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL22A1 284 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COLEC10 284 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCAF13 284 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FZD6 284 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GDF6 284 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TATDN1 284 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFPM2 284 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZHX2 284 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANGPT1 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEPTOR 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DPYS 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DSCC1 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLF10 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAL2 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTBP 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NDUFB9 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OXR1 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POP1 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RGS22 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYBU 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM65 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNFX1 283 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABRA 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP9A 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C8orf76 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCN3 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCN4 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTHRC1 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ENPP2 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83A 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HAS2 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ3 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NTAQ1 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SAMD12 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TSHZ2 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZHX1-C8orf76 282 / 443 cases (64 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARFGEF2 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP6V1C1 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNAS 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNB1 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNS2 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MRPL13 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCALD 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NUDCD1 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSR2 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTDSS1 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RSPO2 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC30A8 281 / 443 cases (63 %) · ssm · TCGA-STAD | — | — | Gastric Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTN 217 / 478 cases (45 %) · ssm · stad_tcga · largest of 7 cohorts | — | — | Gastric Adenocarcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 190 / 478 cases (40 %) · ssm · stad_tcga · largest of 6 cohorts | — | — | Gastric Adenocarcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 134 / 478 cases (28 %) · ssm · stad_tcga · largest of 6 cohorts | — | — | Gastric Adenocarcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 104 / 478 cases (22 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 102 / 478 cases (21 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 101 / 478 cases (21 %) · ssm · stad_tcga · largest of 6 cohorts | — | — | Gastric Adenocarcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 95 / 478 cases (20 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 86 / 478 cases (18 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 85 / 478 cases (18 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 84 / 478 cases (18 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 80 / 478 cases (17 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 77 / 478 cases (16 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TSPOAP1 46 / 295 cases (16 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 73 / 478 cases (15 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 73 / 478 cases (15 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 73 / 478 cases (15 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 69 / 478 cases (14 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 69 / 478 cases (14 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 69 / 478 cases (14 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3CA 65 / 478 cases (14 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HSPG2 63 / 478 cases (13 %) · ssm · stad_tcga · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 62 / 478 cases (13 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 61 / 478 cases (13 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 61 / 478 cases (13 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SACS 60 / 478 cases (13 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ACVR2A 59 / 478 cases (12 %) · ssm · stad_tcga · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 59 / 478 cases (12 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRK2 59 / 478 cases (12 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 59 / 478 cases (12 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 58 / 478 cases (12 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUBN 58 / 478 cases (12 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH3 52 / 436 cases (12 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PSME4 35 / 295 cases (12 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF43 34 / 295 cases (12 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 55 / 478 cases (12 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLEC 55 / 478 cases (12 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 54 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEA 54 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH10 54 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH10 33 / 295 cases (11 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 53 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL12A1 53 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 53 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 48 / 436 cases (11 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RP1 48 / 436 cases (11 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 52 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SEC31A 46 / 431 cases (11 %) · ssm · stad_tcga_gdc | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CIC 51 / 478 cases (11 %) · ssm · stad_tcga | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK3 51 / 478 cases (11 %) · ssm · stad_tcga · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA1 51 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDN1 51 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5B 51 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PXDN 51 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 51 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USP34 31 / 295 cases (11 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GLI3 50 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PREX2 50 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UBR5 50 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO15A 45 / 436 cases (10 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Gastric Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APC 49 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB4 49 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 49 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VPS13B 49 / 478 cases (10 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCHS1 30 / 295 cases (10 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYLK 30 / 295 cases (10 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | POLQ 30 / 295 cases (10 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRD 30 / 295 cases (10 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TACC2 30 / 295 cases (10 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK 44 / 436 cases (10 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC13C 44 / 436 cases (10 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK3 48 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 48 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 48 / 478 cases (10 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRRAP 48 / 478 cases (10 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 47 / 478 cases (9.8 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT2 47 / 478 cases (9.8 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 47 / 478 cases (9.8 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RNF213 47 / 478 cases (9.8 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TG 47 / 478 cases (9.8 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1D 29 / 295 cases (9.8 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SBF1 29 / 295 cases (9.8 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VCAN 29 / 295 cases (9.8 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZC3H13 29 / 295 cases (9.8 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRD8 46 / 478 cases (9.6 %) · ssm · stad_tcga | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1E 46 / 478 cases (9.6 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC2 46 / 478 cases (9.6 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 46 / 478 cases (9.6 %) · ssm · stad_tcga | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC6 46 / 478 cases (9.6 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SDK1 46 / 478 cases (9.6 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTK 46 / 478 cases (9.6 %) · ssm · stad_tcga · largest of 2 cohorts | — | — | Gastric Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ACACB 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADAMTS12 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AKAP13 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DLC1 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN3 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG2 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MAGI2 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RANBP2 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TIAM1 28 / 295 cases (9.5 %) · ssm · stad_tcga_pub | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DST 45 / 478 cases (9.4 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2B 45 / 478 cases (9.4 %) · ssm · stad_tcga · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WHR1 45 / 478 cases (9.4 %) · ssm · stad_tcga | — | — | Gastric Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATP10A 41 / 436 cases (9.4 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Gastric Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH1 41 / 436 cases (9.4 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL7A1 41 / 436 cases (9.4 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Gastric Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RNF43 41 / 436 cases (9.4 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BLTP1 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CMYA5 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL11A1 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH10 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH8 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NAV3 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLXNA4 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRT 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RPL22 44 / 478 cases (9.2 %) · ssm · stad_tcga · largest of 2 cohorts | — | — | Gastric Adenocarcinoma | 2 | Observed | cbioportal | graph → |